Archive for February, 2010

Further doubt cast on virus link to chronic fatigue syndrome

Researchers investigating UK samples have found no association between the controversial xenotropic murine leukemia virus-related virus and chronic fatigue syndrome. Their study calls into question a potential link described late last year by an American research...

Researchers find oncogene is important in pancreatic cancer growth, spread

(PhysOrg.com) -- Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKCi), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKCi in laboratory animals led to a significant decrease in pancreatic tumor growth and...

DeveloGen AG receives US$ 500,000 Funding from the Juvenile Diabetes Research Foundation for Beta Cell Research

Göttingen, 23 February 2010. DeveloGen AG, a company focused on the discovery and development of therapies for the treatment of diabetes and other metabolic diseases announced today that it will receive US$ 500,000 from the Juvenile Diabetes Research Foundation, New York, USA (JDRF). The funds are dedicated to aide in the research of mechanisms for the protection of beta cells. In this two year project titled "Development of Novel Therapeutic Agents Enhancing Human Beta Cell Survival",...

Wisconsin Announces Top Companies to Watch

Yesterday, Wisconsin's Department of Commerce announced their top 30 companies to watch in 2010.  The purpose of the award is to honor second-stage companies that demonstrate high performance in the marketplace, exhibit innovative products, services or processes, or otherwise make their company "worth watching."  Among these companies were numerous pharmaceutical and biotechnology companies whose focus are chronic diseases. The list included the following: EraGen...

An ibuprofen a day could keep Parkinson’s disease away, study suggests

New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a new...

Protein identified that helps heart muscle contract

Researchers have discovered that a protein called B1N1 is necessary for the heart to contract. The findings shed light not only on what makes a heart beat but also on heart failure, a disease where cardiac cells are no longer able to contract and pump blood through the...

Who’s up for a big FDA approval decision in the first half?

Few events can move a biotech stock quite like an FDA decision on a new drug app. And given the agency's rep for somewhat unpredictable behavior, there's no such thing as a sure thing. All of which keeps this guessing game an unending delight for the analysts in the field. TheStreet's veteran biotech analyst Adam Feuerstein offers up a snapshot of 10 public biotech companies facing crucial, looming decisions likely to either fuel their stock price or douse it with a bucket-load of cold...

Tarsa Therapeutics Announces Addition of Senior Level Clinical and Regulatory Expertise

PHILADELPHIA, Feb. 18 PRNewswire -- Tarsa Therapeutics, Inc. today announced the addition of two executives to its senior management team. David Krause, M.D., F.A.C.P., has joined as Chief Medical Officer and Thomas C. Wicks, Ph.D., has joined as Vice President Global Regulatory...

Senesco Technologies announces financial results for quarter ended December 31, 2009

Senesco Technologies, Inc. today reported financial results for the three months ended December 31,...

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

Tioga Pharmaceuticals, Inc. today announced the closing of an $18 million equity financing. Current investors Forward Ventures, New Leaf Venture Partners and BB Biotech Ventures were joined by new investor Genesys Capital...
Get Adobe Flash playerPlugin by wpburn.com wordpress themes